Accustem Sciences Inc. (ACUT) AI Dilution Summary

The disclosed funding position rests on cash of $12,928 at the last reported balance-sheet date, 2026-06-30, set against estimated monthly burn of $103,838. Both figures are carried here exactly as filed, with the balance-sheet date attached to the cash figure. Dilution here is driven primarily by a single live warrant series, 350,000 shares underlying at a $1.06 weighted average exercise price, taken from the 10-Q roll-forward, in which series composition is not disclosed.